Homepage>Company>Media>Pharma News>2016>GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD
GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD